Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Saman Zartab, Nasrin Nassiri Koopaei, Hadi Abbasian, Mansur Nassiri Koopaei & Nasser Nassiri Koopaei. (2020) The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016. Journal of Pharmaceutical Policy and Practice 13:1.
Read now
Read now
Ana V. Pejcic, Georgi Iskrov, Ralitsa Raycheva, Rumen Stefanov & Mihajlo (Michael) Jakovljevic. (2017) Transposition and implementation of EU rare disease policy in Eastern Europe. Expert Review of Pharmacoeconomics & Outcomes Research 17:6, pages 557-566.
Read now
Read now
Ana V. Pejcic & Mihajlo Jakovljevic. (2017) Pharmaceutical expenditure dynamics in the Balkan countries. Journal of Medical Economics 20:10, pages 1013-1017.
Read now
Read now
Articles from other publishers (31)
Eni Tresa, Katarzyna Czabanowska, Timo Clemens, Helmut Brand, Suzanne M. Babich, Vesna Bjegovic-Mikanovic & Genc Burazeri. (2022) Europeanization of health policy in post-communist European societies: Comparison of six Western Balkan countries. Health Policy 126:8, pages 816-823.
Crossref
Crossref
Bogeum Park, Anna Baek, Yoonhee Kim, Yewon Suh, Jungwha Lee, Eunsook Lee, Ju-Yeun Lee, Euni Lee, Jongchan Lee, Hee Sun Park, Eun Sun Kim, Yejee Lim, Nak-Hyun Kim, Jung Hun Ohn & Hye Won Kim. (2022) Clinical and economic impact of medication reconciliation by designated ward pharmacists in a hospitalist-managed acute medical unit. Research in Social and Administrative Pharmacy 18:4, pages 2683-2690.
Crossref
Crossref
Jie Sun, Hui Jin, Fu-Sheng Tsai & Mihajlo Jakovljevic. (2022) A Global Assessment of Sustainable Development: Integrating Socioeconomic, Resource and Environmental Dimensions. Frontiers in Energy Research 10.
Crossref
Crossref
Luka Vončina, Tea Strbad, Jurij Fürst, Maria Dimitrova, Maria Kamusheva, Megi Vila, Ileana Mardare, Kristina Hristova, Andras Harsanyi, Dragana Atanasijević, Igor Banović & Ana Bobinac. (2021) Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe. Applied Health Economics and Health Policy 19:6, pages 915-927.
Crossref
Crossref
Hamid Bokhary, Krisna N. A. Pangesti, Harunor Rashid, Moataz Abd El Ghany & Grant A. Hill-Cawthorne. (2021) Travel-Related Antimicrobial Resistance: A Systematic Review. Tropical Medicine and Infectious Disease 6:1, pages 11.
Crossref
Crossref
Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett & Arnold G. Vulto. (2021) The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures. Frontiers in Pharmacology 11.
Crossref
Crossref
Đurđa Vukićević, Ursula Rochau, Aleksandar Savić, Monika Schaffner, Milica Jevđević, Igor Stojkov, Gaby Sroczynski, Wolfgang Willenbacher, Beate Jahn & Uwe Siebert. (2020) Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia. Slovenian Journal of Public Health 59:2, pages 83-91.
Crossref
Crossref
Nenad Miljković, Brian Godman, Eline van Overbeeke, Milena Kovačević, Karyofyllis Tsiakitzis, Athina Apatsidou, Anna Nikopoulou, Cristina Garcia Yubero, Laura Portillo Horcajada, Gunar Stemer, Darija Kuruc-Poje, Thomas De Rijdt, Tomasz Bochenek, Isabelle Huys & Branislava Miljković. (2020) Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals. Frontiers in Medicine 7.
Crossref
Crossref
Kristijan Krstic, Katarina Janicijevic, Yuriy Timofeyev, Evgeny V. Arsentyev, Gvozden Rosic, Sergey Bolevich, Vladimir Reshetnikov & Mihajlo B. Jakovljevic. (2019) Dynamics of Health Care Financing and Spending in Serbia in the XXI Century. Frontiers in Public Health 7.
Crossref
Crossref
Dessalegn Asmelashe Gelayee, Gashaw Binega Mekonnen & Mequanent Kassa Birarra. (2018) Involvement of community pharmacists in continuing professional development (CPD): a baseline survey in Gondar, Northwest Ethiopia. Globalization and Health 14:1.
Crossref
Crossref
Klára Boruzs, Attila Juhász, Csilla Nagy, Zoltán Szabó, Mihajlo Jakovljevic, Klára Bíró & Róza Ádány. (2018) High Inequalities Associated With Socioeconomic Deprivation in Cardiovascular Disease Burden and Antihypertensive Medication in Hungary. Frontiers in Pharmacology 9.
Crossref
Crossref
Zdenko Tomić, Ana Tomas, Zuzana Benšova, Ljiljana Tomić, Olga Horvat, Ivan Varga, Milica Paut Kusturica & Ana Sabo. (2018) Challenges of Providing Access to Cutting-Edge Cancer Medicines in the Countries of Eastern Europe. Frontiers in Public Health 6.
Crossref
Crossref
Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Ðermanović, Janja Bojanić, Jurij Fürst, Amanj B. Kurdi & Brian Godman. (2018) Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications. Frontiers in Pharmacology 9.
Crossref
Crossref
Olga Horvat, Vesna Mijatović, Boris Milijasević, Ana Tomas, Milica Paut Kusturica, Zdenko Tomić & Ana Sabo. (2018) Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District, Serbia, and Some Scandinavian Countries?. Frontiers in Public Health 6.
Crossref
Crossref
Tanja Pekez-Pavlisko, Maja Racic & Srebrenka Kusmuk. (2017) Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries. Frontiers in Public Health 5.
Crossref
Crossref
Nemanja Rancic, Neven Vavic, Katarina Obrencevic, Filip Pilipovic & Viktorija Dragojevic-Simic. (2017) Tacrolimus Utilization and Expenditure in Serbia. Frontiers in Public Health 5.
Crossref
Crossref
Viktorija Dragojevic-Simic, Nemanja Rancic, Dusica Stamenkovic & Radoje Simic. (2017) Utilization of Parenteral Morphine by Application of ATC/DDD Methodology: Retrospective Study in the Referral Teaching Hospital. Frontiers in Public Health 5.
Crossref
Crossref
Katarina Vojvodic, Zorica Terzic-Supic, Milena Santric-Milicevic & Gert W. Wolf. (2017) Socio-Economic Inequalities, Out-of-Pocket Payment and Consumers' Satisfaction with Primary Health Care: Data from the National Adult Consumers' Satisfaction Survey in Serbia 2009–2015. Frontiers in Pharmacology 8.
Crossref
Crossref
Mihajlo Jakovljevic & Mirjana Varjacic. (2017) Commentary: Do health care workforce, population, and service provision significantly contribute to the total health expenditure? An econometric analysis of Serbia. Frontiers in Pharmacology 8.
Crossref
Crossref
Anthony Pezzola & Cassandra M. Sweet. (2016) Global pharmaceutical regulation: the challenge of integration for developing states. Globalization and Health 12:1.
Crossref
Crossref
Aleksandar Cvetkovic, Danijela Cvetkovic, Vladislava Stojic & Nebojsa Zdravkovic. (2016) Length of Hospital Stay and Bed Occupancy Rates in Former Yugoslav Republics 1989–2015. Frontiers in Pharmacology 7.
Crossref
Crossref
Aleksandra Kovacevic, Nemanja Rancic, Zoran Segrt & Viktorija Dragojevic-Simic. (2016) Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia. Frontiers in Pharmacology 7.
Crossref
Crossref
Nemanja Rancic, Viktorija Dragojevic-Simic, Neven Vavic, Aleksandra Kovacevic, Zoran Segrt & Natasa Djordjevic. (2016) Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature. Frontiers in Public Health 4.
Crossref
Crossref
Svetlana Radevic, Sanja Kocic & Mihajlo Jakovljevic. (2016) Self-Assessed Health and Socioeconomic Inequalities in Serbia: Data from 2013 National Health Survey. Frontiers in Pharmacology 7.
Crossref
Crossref
Mihajlo Jakovljevic, Marija Lazarevic, Olivera Milovanovic & Tatjana Kanjevac. (2016) The New and Old Europe: East-West Split in Pharmaceutical Spending. Frontiers in Pharmacology 7.
Crossref
Crossref
Mihajlo (Michael) Jakovljevic, Marija Lazarevic, Milena Jurisevic & Mirjana R. Jovanovic. (2015) When cure becomes an illness—abuse of addictive prescription medicines. Frontiers in Pharmacology 6.
Crossref
Crossref
Tamara Petrusic & Mihajlo Jakovljevic. (2015) Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska. Frontiers in Public Health 3.
Crossref
Crossref
Vesna Velickovic, Aleksandra Simovic, Gordana Lazarevic, Marija Lazarevic & Mihajlo Jakovljevic. (2015) Improvements in Neonatal and Childhood Medical Care – Perspective from the Balkans. Frontiers in Public Health 3.
Crossref
Crossref
Veselin Dickov. (2015) Peculiarity of Pharmaceutical Marketing in Serbia. Frontiers in Public Health 3.
Crossref
Crossref
Tatjana Kanjevac. (2015) Dental Services Funding and Affordability in Serbia – Decade-Long Perspective. Frontiers in Public Health 3.
Crossref
Crossref
Vojislav Cupurdija. (2015) Economic Impact of Leading Prosperity Diseases: COPD in South East Europe. Frontiers in Public Health 3.
Crossref
Crossref